Commissioner Nominee Reveals More Complicated Finances Ahead Of Second Confirmation Process

 
• By Derrick Gingery
  
Robert Califf. (Alamy)
Robert Califf's financial disclosure report indicates his IRA includes holdings in several pharma companies. • Source: Alamy

More from US FDA

More from Agency Leadership